Homologous Recombination Deficient-Positive Malignancies Agnostic
specificA DNA repair abnormality caused by mutations in one or more genes that are involved in homologous recombination repair. Deficient homologous recombination is associated with numerous neoplastic diseases and developmental disorders related to chromosomal nondisjunction.
7
Centers
0
Active Trials
—
Cancer Funding
Top Centers for Homologous Recombination Deficient-Positive Malignancies Agnostic(7)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive | 57.1 |
| 2 | Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive | 57.1 |
| 3 | UPMC Hillman Cancer CenterPittsburgh, PA NCI Comprehensive | 57.1 |
| 4 | Moffitt Cancer CenterTampa, FL NCI Comprehensive | 57.1 |
| 5 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive | 57.1 |
| 6 | Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical | 57.1 |
| 7 | Boston University Cancer CenterBoston, MA | 57.1 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →